DBV Technologies SA (DBVT)
0.682
-0.01
(-1.08%)
USD |
NASDAQ |
Apr 26, 16:00
0.6811
0.00 (0.00%)
Pre-Market: 20:00
DBV Technologies Cash from Financing (TTM): 6.767M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 6.767M |
September 30, 2023 | 6.673M |
June 30, 2023 | 6.692M |
March 31, 2023 | 194.24M |
December 31, 2022 | 194.12M |
September 30, 2022 | 194.78M |
June 30, 2022 | 194.42M |
Date | Value |
---|---|
March 31, 2022 | -0.295M |
December 31, 2021 | 0.274M |
September 30, 2021 | -0.179M |
June 30, 2021 | -0.053M |
March 31, 2021 | -0.623M |
December 31, 2020 | 149.55M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.623M
Minimum
Mar 2021
194.78M
Maximum
Sep 2022
72.80M
Average
6.692M
Median
Jun 2023
Cash from Financing (TTM) Benchmarks
Edap TMS SA | -0.9863M |
Cellectis SA | 36.24M |
Biophytis SA | 7.617M |
Genfit SA | -- |
Adaptimmune Therapeutics PLC | 0.88M |